Filing Flows › Procept BioRobotics (PRCT) › Q2 2025
Procept BioRobotics (PRCT) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 7, 2025
Procept BioRobotics (PRCT) reported revenue of $79.2M for the second quarter 2025 (Q2 2025), +48% from a year earlier and +14% from the quarter before. Operating margin was -28.0%, net loss $19.6M (24.7% of revenue).
Procept BioRobotics, Q2 2025: revenue $79.2M (+48% year over year), operating margin -28.0%, net loss $19.6M, operating cash flow −$15.0M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $79.2M | +14% | +48% |
| Operating profit | −$22.2M | — | — |
| Net earnings | −$19.6M | — | — |
| Operating cash flow | −$15.0M | — | — |
What changed
Revenue was $79.2M in Q2 2025, up 48% year over year and up 14% from the previous quarter.
Gross margin was 65.4%, up 6.3 points from a year earlier. Operating costs exceeded revenue by $22.2M, an operating margin of -28.0%. Operating expenses grew 27% against revenue growth of 48%. The fastest-growing cost line was SG&A (+38%). The quarter ended with a net loss of $19.6M, narrower than the previous quarter's $24.7M loss.
Operating cash flow was −$15.0M. Non-cash charges added back $1.6M of depreciation and amortization and $12.2M of share-based compensation. Working capital and other items used $9.2M. Capital expenditures of $2.8M exceeded it, leaving free cash flow of −$17.8M.
Questions
What was Procept BioRobotics' revenue in the second quarter 2025?
Procept BioRobotics (PRCT) reported revenue of $79.2M for the second quarter 2025 (Q2 2025), +48% from a year earlier and +14% from the quarter before.
Was Procept BioRobotics profitable in the second quarter 2025?
Operating loss was $22.2M (-28.0% of revenue) and net loss $19.6M.